Abstract
Previous studies have identified dementia as a risk factor for death from coronavirus disease 2019 (COVID-19). However, it is unclear whether Alzheimer's disease (AD) is an independent risk factor for COVID-19 case fatality rate. In a retrospective cohort study, we identified 387,841 COVID-19 patients through TriNetX. After adjusting for demographics and comorbidities, we found that AD patients had higher odds of dying from COVID-19 compared to patients without AD (Odds Ratio: 1.20, 95%confidence interval: 1.09-1.32, p < 0.001). Interestingly, we did not observe increased mortality from COVID-19 among patients with vascular dementia. These data are relevant to the evolving COVID-19 pandemic.
Author supplied keywords
Cite
CITATION STYLE
Zhang, Q., Schultz, J. L., Aldridge, G. M., Simmering, J. E., Kim, Y., Ogilvie, A. C., & Narayanan, N. S. (2021). COVID-19 Case Fatality and Alzheimer’s Disease. Journal of Alzheimer’s Disease, 84(4), 1447–1452. https://doi.org/10.3233/JAD-215161
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.